Overview
AVTX market data
Price History
No market bars yet for AVTX. This page will populate once the next provider sweep lands.
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for AVTX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Leerink Partners Initiates Coverage On Avalo Therapeutics with Outperform Rating, Announces Price Target of $38Benzinga · Jul 6, 2026, 12:15 PM
Avalo Therapeutics to Join the Russell 2000® and Russell 3000® IndexesGlobenewswire Inc · Jun 26, 2026, 11:15 AM
Avalo Therapeutics To Be Added To Small-Cap Russell 2000 Index And Broad-Market Russell 3000 Index, Effective June 26Benzinga · Jun 26, 2026, 11:10 AM
8-K filing — Avalo Therapeutics, Inc. (AVTX)SEC EDGAR · Jun 23, 2026, 11:01 AM
Avalo Therapeutics Advances AVTX-010, Long-Acting Next-Gen Anti-IL-1β mAB With Potential For Development In HS And Additional Inflammatory Disorders; IND Submission Planned For H1 2027Benzinga · Jun 16, 2026, 11:10 AM
This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For MondayBenzinga · Jun 15, 2026, 1:20 PM
This FormFactor Analyst Turns Bullish; Here Are Top 3 Upgrades For FridayBenzinga · Jun 12, 2026, 1:10 PM
This Sailpoint Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For FridayBenzinga · Jun 12, 2026, 12:55 PM
This Keurig Dr Pepper Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For FridayBenzinga · Jun 12, 2026, 11:15 AM
Citizens Maintains Market Outperform on Avalo Therapeutics, Lowers Price Target to $55Benzinga · May 14, 2026, 2:08 PM